Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial. Cao M, Lu H, Yan S, Pang H, et al. BMC Cancer 2023;23:463.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cao M, Lu H, Yan S, Pang H, et al. Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial. BMC Cancer 2023;23:463.
PMID: 37208633